Literature DB >> 12780698

Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

E R Popa1, C A Stegeman, N A Bos, C G M Kallenberg, J W Cohen Tervaert.   

Abstract

In Wegener's granulomatosis (WG), a form of autoimmune systemic vasculitis, chronic carriage of Staphylococcus aureus constitutes a risk factor for the development of exacerbations. Circulating T cells in this disease are persistently activated, suggesting the presence of a chronic stimulus. A causal link between chronic carriage of S. aureus and chronic T cell activation in WG is conceivable, because S. aureus produces superantigens (SAg), which are potent T cell stimulators. Superantigenic stimulation of T cells results in expansion of T cell subsets expressing SAg-binding T cell receptor V-beta (Vbeta) chains. In the present study we hypothesized that in WG the presence of staphylococcal SAg is accompanied by expansion of SAg-reacting T cell subsets. We tested our hypothesis in a cross-sectional and a longitudinal study in which the association between seven staphylococcal SAg genes [typed by poplymerase chain reaction (PCR)], eight SAg-binding Vbeta chains and four SAg-non-binding Vbeta chains (assessed by flow-cytometry) was assessed. Both studies showed that T cell expansions were present at a significantly higher rate in WG patients than in healthy individuals, but were not associated with the presence of either S. aureus or its SAg. Moreover, T cell expansions were generally of small extent, and did not appear simultaneously in both CD4 and CD8 subsets. We conclude that in WG S. aureus effects its supposed pathogenic function by a mechanism other than superantigenic T cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780698      PMCID: PMC1808727          DOI: 10.1046/j.1365-2249.2003.02157.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor V beta 2 gene usage in microscopic polyarteritis.

Authors:  I J Simpson; M A Skinner; A Geursen; J S Peake; W G Abbott; J D Fraser; C M Lockwood; P L Tan
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens.

Authors:  B Fleischer; A Necker; C Leget; B Malissen; F Romagne
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

3.  Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease.

Authors:  Y Yamashiro; S Nagata; S Oguchi; T Shimizu
Journal:  Pediatr Res       Date:  1996-02       Impact factor: 3.756

Review 4.  Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.

Authors:  P Heeringa; E Brouwer; J W Tervaert; J J Weening; C G Kallenberg
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

Review 5.  B-cell superantigens.

Authors:  G J Silverman
Journal:  Immunol Today       Date:  1997-08

6.  Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.

Authors:  D Y Leung; K E Sullivan; T F Brown-Whitehorn; A P Fehringer; S Allen; T H Finkel; R L Washington; R Makida; P M Schlievert
Journal:  Pediatr Res       Date:  1997-09       Impact factor: 3.756

7.  T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis.

Authors:  R Giscombe; J Grunewald; S Nityanand; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.

Authors:  K Kanclerski; B Söderquist; M Kjellgren; H Holmberg; R Möllby
Journal:  J Med Microbiol       Date:  1996-03       Impact factor: 2.472

9.  Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

Authors:  C A Stegeman; J W Tervaert; P E de Jong; C G Kallenberg
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

10.  Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis.

Authors:  T Origuchi; K Eguchi; Y Kawabe; I Yamashita; A Mizokami; H Ida; S Nagataki
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

View more
  24 in total

1.  Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro.

Authors:  E A Torheim; A Yndestad; V Bjerkeli; B Halvorsen; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

2.  Analysis of T-cell receptor usage in myeloperoxidase--antineutrophil cytoplasmic antibody-associated renal vasculitis.

Authors:  Kouichi Hirayama; Takashi Ishizu; Homare Shimohata; Yasunori Miyamoto; Tomoko Kakita; Miho Nagai; Yujiro Ogawa; Shogo Fujita; Aki Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2009-10-07       Impact factor: 2.801

Review 3.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 4.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Julia Flint; Matthew D Morgan; Caroline O S Savage
Journal:  Rheum Dis Clin North Am       Date:  2010-06-23       Impact factor: 2.670

5.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

Review 6.  Pathogenesis of ANCA-associated vasculitis, an update.

Authors:  Cees G M Kallenberg
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 7.  Small-vessel vasculitis.

Authors:  Antonio Iglesias-Gamarra; José Félix Restrepo; Eric L Matteson
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

8.  Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study.

Authors:  Susan L Hogan; Glinda S Cooper; David A Savitz; Leena A Nylander-French; Christine G Parks; Hyunsook Chin; Caroline E Jennette; Sofia Lionaki; J Charles Jennette; Ronald J Falk
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-07       Impact factor: 8.237

9.  Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.

Authors:  Christian Pagnoux; Susan L Hogan; Hyunsook Chin; J Charles Jennette; Ronald J Falk; Loïc Guillevin; Patrick H Nachman
Journal:  Arthritis Rheum       Date:  2008-09

10.  Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease.

Authors:  Keiichi Sumida; Yoshifumi Ubara; Junichi Hoshino; Noriko Hayami; Tatsuya Suwabe; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Naoki Sawa; Kenmei Takaichi; Kenichi Ohashi
Journal:  BMC Nephrol       Date:  2013-04-23       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.